HomeNewsBusiness CornerResourcesProduct InformationContinuing EducationTechnologyLegislative

Update Profile
Site Map
Contact Us
Logout

Welcome !

Medicare DME Program

DME Alert Blog

 

Bill Popomaronis, R.Ph., NCPA vice president, home health and long term care pharmacy services, provides his thoughts and explanations on the latest DME information from CMS.


Tuesday, April 22, 2008

Accreditation Required for Nebulizer, Enteral Sales; but NOT Part B Drugs

In a recent conference call, CMS clarified that a pharmacy must be accredited if it supplies nebulizers (i.e., DMEPOS) for Part B drugs, but not if it supplies only Part B drugs and no DME. Thus, if a customer obtains Part B drugs from a pharmacy, but obtains the nebulizer elsewhere, the pharmacy does not need to be accredited.

However, CMS emphasized that enteral nutrients, equipment, and supplies are considered DMEPOS for purposes of the Competitive Bidding Program, so a pharmacy supplying these items requires accreditation.

posted by dme alert service @ 6:38 AM 

Bayer HealthCare, Diabetes Care, has underwritten the costs of this communication. The information expressed in this communication are the views of NCPA. Bayer is not responsible for the accuracy of the information expressed in this communication. Any questions related to DME Accreditation and/or Competitive Bidding for DMEPOS should be directed to the Centers for Medicare and Medicaid Services or NCPA.